{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:02:34Z","timestamp":1786114954549,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Instituto de la Salud Carlos III (ISCIII) AES2022","award":["PI22\/01496"],"award-info":[{"award-number":["PI22\/01496"]}]},{"name":"Sara Borrell project","award":["CD22\/00026"],"award-info":[{"award-number":["CD22\/00026"]}]},{"name":"Spanish Association Against Cancer","award":["PRDPM246418BEDO"],"award-info":[{"award-number":["PRDPM246418BEDO"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54795-4","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:43:12Z","timestamp":1779882192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinct epigenetic alterations and accelerated mitotic aging define second primary breast cancers"],"prefix":"10.1038","volume":"16","author":[{"given":"Andr\u00e9s F.","family":"Bedoya-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier I. J.","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Llin\u00e0s\u2011Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Ensenyat-Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy J.","family":"Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"I\u00f1iguez\u2011Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Morote-Llabr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Matsuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3258-8852","authenticated-orcid":false,"given":"Diego M.","family":"Marzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3929-0354","authenticated-orcid":false,"given":"Melanie","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"54795_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.70011","volume":"75","author":"NS Wagle","year":"2025","unstructured":"Wagle, N. S. et al. Cancer treatment and survivorship statistics, 2025. CA Cancer J. Clin. 75, 277\u2013279. https:\/\/doi.org\/10.3322\/caac.70011 (2025).","journal-title":"CA Cancer J. Clin."},{"key":"54795_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3857\/roj.2018.00290","volume":"36","author":"CB Dracham","year":"2018","unstructured":"Dracham, C. B., Shankar, A. & Madan, R. Radiation induced secondary malignancies: a review article. Radiat. Oncol. J. 36, 85\u201394. https:\/\/doi.org\/10.3857\/roj.2018.00290 (2018).","journal-title":"Radiat. Oncol. J."},{"key":"54795_CR3","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1200\/JCO.2015.62.3314","volume":"34","author":"TO Henderson","year":"2016","unstructured":"Henderson, T. O. et al. Breast cancer risk in childhood cancer survivors without a history of chest radiotherapy: A report from the childhood cancer survivor study. J. Clin. Oncol. 34, 910\u2013918. https:\/\/doi.org\/10.1200\/JCO.2015.62.3314 (2016).","journal-title":"J. Clin. Oncol."},{"key":"54795_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/jnci\/djq238","volume":"102","author":"DL Friedman","year":"2010","unstructured":"Friedman, D. L. et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the childhood cancer survivor study. J. Natl. Cancer Inst. 102, 1083\u20131095. https:\/\/doi.org\/10.1093\/jnci\/djq238 (2010).","journal-title":"J. Natl. Cancer Inst."},{"key":"54795_CR5","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1001\/jama.2011.747","volume":"305","author":"RC Reulen","year":"2011","unstructured":"Reulen, R. C. et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. Jama 305, 2311\u20132319. https:\/\/doi.org\/10.1001\/jama.2011.747 (2011).","journal-title":"Jama"},{"key":"54795_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/s1470-2045(18)30903-3","volume":"20","author":"CJ Bright","year":"2019","unstructured":"Bright, C. J. et al. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study. Lancet Oncol. 20, 531\u2013545. https:\/\/doi.org\/10.1016\/s1470-2045(18)30903-3 (2019).","journal-title":"Lancet Oncol."},{"key":"54795_CR7","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/jnci\/djac091","volume":"114","author":"H Sung","year":"2022","unstructured":"Sung, H. et al. Subsequent primary cancer risk among 5-year survivors of adolescent and young adult cancers. J. Natl. Cancer Inst. 114, 1095\u20131108. https:\/\/doi.org\/10.1093\/jnci\/djac091 (2022).","journal-title":"J. Natl. Cancer Inst."},{"key":"54795_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/cncr.29685","volume":"122","author":"JS Lee","year":"2016","unstructured":"Lee, J. S. et al. Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Cancer 122, 116\u2013123. https:\/\/doi.org\/10.1002\/cncr.29685 (2016).","journal-title":"Cancer"},{"key":"54795_CR9","doi-asserted-by":"publisher","first-page":"e2353331","DOI":"10.1001\/jamanetworkopen.2023.53331","volume":"7","author":"S Xu","year":"2024","unstructured":"Xu, S., Murtagh, S., Han, Y., Wan, F. & Toriola, A. T. Breast cancer incidence among US women aged 20 to 49 years by race, stage, and hormone receptor status. JAMA Netw. Open. 7, e2353331\u2013e2353331. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.53331 (2024).","journal-title":"JAMA Netw. Open."},{"key":"54795_CR10","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1001\/jamaoncol.2017.0465","volume":"3","author":"THM Keegan","year":"2017","unstructured":"Keegan, T. H. M., Bleyer, A., Rosenberg, A. S., Li, Q. & Goldfarb, M. Second primary malignant neoplasms and survival in adolescent and young adult cancer survivors. JAMA Oncol. 3, 1554\u20131557. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0465 (2017).","journal-title":"JAMA Oncol."},{"key":"54795_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/cncr.29200","volume":"121","author":"C Sadler","year":"2015","unstructured":"Sadler, C. & Goldfarb, M. Comparison of primary and secondary breast cancers in adolescents and young adults. Cancer 121, 1295\u20131302. https:\/\/doi.org\/10.1002\/cncr.29200 (2015).","journal-title":"Cancer"},{"key":"54795_CR12","doi-asserted-by":"publisher","first-page":"8118","DOI":"10.1245\/s10434-021-10340-3","volume":"28","author":"CAM Sauder","year":"2021","unstructured":"Sauder, C. A. M., Li, Q., Bold, R. J., Ruddy, K. J. & Keegan, T. H. M. Secondary breast cancer sociodemographic characteristics and survival by age group. Ann. Surg. Oncol. 28, 8118\u20138127. https:\/\/doi.org\/10.1245\/s10434-021-10340-3 (2021).","journal-title":"Ann. Surg. Oncol."},{"key":"54795_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41523-022-00447-5","volume":"8","author":"Z Deng","year":"2022","unstructured":"Deng, Z., Jones, M. R., Wang, M. C. & Visvanathan, K. Mortality after second malignancy in breast cancer survivors compared to a first primary cancer: a nationwide longitudinal cohort study. npj Breast Cancer. 8, 82. https:\/\/doi.org\/10.1038\/s41523-022-00447-5 (2022).","journal-title":"npj Breast Cancer"},{"key":"54795_CR14","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/s41416-021-01549-w","volume":"125","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Cardiovascular mortality among cancer survivors who developed breast cancer as a second primary malignancy. Br. J. Cancer. 125, 1450\u20131458. https:\/\/doi.org\/10.1038\/s41416-021-01549-w (2021).","journal-title":"Br. J. Cancer"},{"key":"54795_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s43856-023-00311-y","volume":"3","author":"M Ensenyat-Mendez","year":"2023","unstructured":"Ensenyat-Mendez, M. et al. Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer. Commun. Med. 3, 93. https:\/\/doi.org\/10.1038\/s43856-023-00311-y (2023).","journal-title":"Commun. Med."},{"key":"54795_CR16","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.5114\/wo.2014.47136","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak, K., Czerwi\u0144ska, P. & Wiznerowicz, M. The cancer genome atlas (TCGA): an immeasurable source of knowledge. Contemp. Oncol. 19, A68\u201377. https:\/\/doi.org\/10.5114\/wo.2014.47136 (2015).","journal-title":"Contemp. Oncol."},{"key":"54795_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346\u2013352. https:\/\/doi.org\/10.1038\/nature10983 (2012).","journal-title":"Nature"},{"key":"54795_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13073-015-0131-9","volume":"7","author":"LH Saal","year":"2015","unstructured":"Saal, L. H. et al. The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine. Genome Med. 7, 20. https:\/\/doi.org\/10.1186\/s13073-015-0131-9 (2015).","journal-title":"Genome Med."},{"key":"54795_CR19","doi-asserted-by":"publisher","unstructured":"Bedoya-L\u00f3pez, A. F. et al. Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer. npj Precis Onc. 9 https:\/\/doi.org\/10.1038\/s41698-025-01023-3 (2025).","DOI":"10.1038\/s41698-025-01023-3"},{"key":"54795_CR20","first-page":"1027","volume":"9","author":"C Behrens","year":"2000","unstructured":"Behrens, C. et al. Molecular changes in second primary lung and breast cancers after therapy for Hodgkin\u2019s disease1. Cancer Epidemiol. Biomarkers Prev. 9, 1027\u20131035 (2000).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"54795_CR21","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.7150\/ijbs.21635","volume":"13","author":"YS Sun","year":"2017","unstructured":"Sun, Y. S. et al. Risk factors and preventions of breast cancer. Int. J. Biol. Sci. 13, 1387\u20131397. https:\/\/doi.org\/10.7150\/ijbs.21635 (2017).","journal-title":"Int. J. Biol. Sci."},{"key":"54795_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cell.2022.12.027","volume":"186","author":"JH Yang","year":"2023","unstructured":"Yang, J. H. et al. Loss of epigenetic information as a cause of mammalian aging. Cell 186, 305\u2013326e327. https:\/\/doi.org\/10.1016\/j.cell.2022.12.027 (2023).","journal-title":"Cell"},{"key":"54795_CR23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41392-022-01211-8","volume":"7","author":"K Wang","year":"2022","unstructured":"Wang, K. et al. Epigenetic regulation of aging: implications for interventions of aging and diseases. Signal. Transduct. Target. Ther. 7, 374. https:\/\/doi.org\/10.1038\/s41392-022-01211-8 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"54795_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","volume":"19","author":"S Horvath","year":"2018","unstructured":"Horvath, S. & Raj, K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat. Rev. Genet. 19, 371\u2013384. https:\/\/doi.org\/10.1038\/s41576-018-0004-3 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"54795_CR25","doi-asserted-by":"publisher","unstructured":"Horvath, S. Erratum to: DNA methylation age of human tissues and cell types. Genome Biol. 16 https:\/\/doi.org\/10.1186\/s13059-015-0649-6 (2015).","DOI":"10.1186\/s13059-015-0649-6"},{"key":"54795_CR26","doi-asserted-by":"publisher","unstructured":"Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14 (R115). https:\/\/doi.org\/10.1186\/gb-2013-14-10-r115 (2013).","DOI":"10.1186\/gb-2013-14-10-r115"},{"key":"54795_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41514-022-00085-y","volume":"8","author":"L de Camillo","year":"2022","unstructured":"de Camillo, L., Lapierre, L. P., Singh, R. & L. R. & A pan-tissue DNA-methylation epigenetic clock based on deep learning. NPJ Aging. 8, 4. https:\/\/doi.org\/10.1038\/s41514-022-00085-y (2022).","journal-title":"npj Aging"},{"key":"54795_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.18632\/aging.101414","volume":"10","author":"ME Levine","year":"2018","unstructured":"Levine, M. E. et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging 10, 573\u2013591. https:\/\/doi.org\/10.18632\/aging.101414 (2018).","journal-title":"Aging"},{"key":"54795_CR29","doi-asserted-by":"publisher","unstructured":"Yang, Z. et al. Correlation of an epigenetic mitotic clock with cancer risk. Genome Biol. 17 https:\/\/doi.org\/10.1186\/s13059-016-1064-3 (2016).","DOI":"10.1186\/s13059-016-1064-3"},{"key":"54795_CR30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1126\/science.1260825","volume":"347","author":"C Tomasetti","year":"2015","unstructured":"Tomasetti, C. & Vogelstein, B. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Sci. (New York N Y). 347, 78\u201381. https:\/\/doi.org\/10.1126\/science.1260825 (2015).","journal-title":"Sci. (New York N Y)"},{"key":"54795_CR31","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1245\/s10434-018-6582-7","volume":"25","author":"AN Graff-Baker","year":"2018","unstructured":"Graff-Baker, A. N. et al. Epigenomic and transcriptomic characterization of secondary breast cancers. Ann. Surg. Oncol. 25, 3082\u20133087. https:\/\/doi.org\/10.1245\/s10434-018-6582-7 (2018).","journal-title":"Ann. Surg. Oncol."},{"key":"54795_CR32","doi-asserted-by":"publisher","unstructured":"Moossdorff, M. et al. Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research. J. Natl. Cancer Inst. 106 https:\/\/doi.org\/10.1093\/jnci\/dju288 (2014).","DOI":"10.1093\/jnci\/dju288"},{"key":"54795_CR33","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","volume":"33","author":"Y Tian","year":"2017","unstructured":"Tian, Y. et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics 33, 3982\u20133984. https:\/\/doi.org\/10.1093\/bioinformatics\/btx513 (2017).","journal-title":"Bioinformatics"},{"key":"54795_CR34","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1093\/nar\/gkw967","volume":"45","author":"W Zhou","year":"2016","unstructured":"Zhou, W., Laird, P. W. & Shen, H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 45, e22\u2013e22. https:\/\/doi.org\/10.1093\/nar\/gkw967 (2016).","journal-title":"Nucleic Acids Res."},{"key":"54795_CR35","doi-asserted-by":"publisher","unstructured":"Aran, D., Sirota, M. & Butte, A. J. Systematic pan-cancer analysis of tumour purity. Nat. Commun. 6 https:\/\/doi.org\/10.1038\/ncomms9971 (2015).","DOI":"10.1038\/ncomms9971"},{"key":"54795_CR36","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico, A. et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71. https:\/\/doi.org\/10.1093\/nar\/gkv1507 (2016).","journal-title":"Nucleic Acids Res."},{"key":"54795_CR37","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1038\/s41467-018-05570-1","volume":"9","author":"A Chakravarthy","year":"2018","unstructured":"Chakravarthy, A. et al. Pan-cancer deconvolution of tumour composition using DNA methylation. Nat. Commun. 9, 3220. https:\/\/doi.org\/10.1038\/s41467-018-05570-1 (2018).","journal-title":"Nat. Commun."},{"key":"54795_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1756-8935-8-6","volume":"8","author":"TJ Peters","year":"2015","unstructured":"Peters, T. J. et al. De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin. 8, 6. https:\/\/doi.org\/10.1186\/1756-8935-8-6 (2015).","journal-title":"Epigenetics Chromatin"},{"key":"54795_CR39","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L. G. & He, Q. Y. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382\u20132383. https:\/\/doi.org\/10.1093\/bioinformatics\/btv145 (2015).","journal-title":"Bioinformatics"},{"key":"54795_CR40","doi-asserted-by":"publisher","first-page":"zcac008","DOI":"10.1093\/narcan\/zcac008","volume":"4","author":"J Ankill","year":"2022","unstructured":"Ankill, J. et al. Epigenetic alterations at distal enhancers are linked to proliferation in human breast cancer. NAR Cancer. 4, zcac008. https:\/\/doi.org\/10.1093\/narcan\/zcac008 (2022).","journal-title":"NAR Cancer"},{"key":"54795_CR41","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41467-017-00510-x","volume":"8","author":"T Fleischer","year":"2017","unstructured":"Fleischer, T. et al. DNA methylation at enhancers identifies distinct breast cancer lineages. Nat. Commun. 8, 1379. https:\/\/doi.org\/10.1038\/s41467-017-00510-x (2017).","journal-title":"Nat. Commun."},{"key":"54795_CR42","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bioinformatics\/btv560","volume":"32","author":"B Phipson","year":"2016","unstructured":"Phipson, B., Maksimovic, J. & Oshlack, A. missMethyl: an R package for analyzing data from Illumina\u2019s HumanMethylation450 platform. Bioinformatics 32, 286\u2013288. https:\/\/doi.org\/10.1093\/bioinformatics\/btv560 (2016).","journal-title":"Bioinformatics"},{"key":"54795_CR43","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.gpb.2022.04.008","volume":"21","author":"Z Gu","year":"2023","unstructured":"Gu, Z., Hubschmann, D. Simplify enrichment: A bioconductor package for clustering and visualizing functional enrichment results. Genomics Proteom. Bioinf. 21, 190\u2013202. https:\/\/doi.org\/10.1016\/j.gpb.2022.04.008 (2023).","journal-title":"Genomics Proteom. Bioinf."},{"key":"54795_CR44","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"54795_CR45","doi-asserted-by":"publisher","unstructured":"Yu, G. Thirteen years of clusterProfiler. Innov. (Camb). (5), 100722. https:\/\/doi.org\/10.1016\/j.xinn.2024.100722 (2024).","DOI":"10.1016\/j.xinn.2024.100722"},{"key":"54795_CR46","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D. C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28, 1747\u20131756. https:\/\/doi.org\/10.1101\/gr.239244.118 (2018).","journal-title":"Genome Res."},{"key":"54795_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"EP Consortium","year":"2012","unstructured":"Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374. https:\/\/doi.org\/10.1038\/nature11247 (2012).","journal-title":"Nature"},{"key":"54795_CR48","doi-asserted-by":"publisher","unstructured":"P\u00e9rez, R. F., Tejedor, J. R., Bay\u00f3n, G. F., Fern\u00e1ndez, A. F. & Fraga, M. F. Distinct chromatin signatures of DNA hypomethylation in aging and cancer. Aging Cell. 17 https:\/\/doi.org\/10.1111\/acel.12744 (2018).","DOI":"10.1111\/acel.12744"},{"key":"54795_CR49","doi-asserted-by":"publisher","unstructured":"Prlic, A. et al. Software for computing and annotating genomic ranges. PLoS Comput. Biol. 9 https:\/\/doi.org\/10.1371\/journal.pcbi.1003118 (2013).","DOI":"10.1371\/journal.pcbi.1003118"},{"key":"54795_CR50","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","volume":"33","author":"JR Conway","year":"2017","unstructured":"Conway, J. R., Lex, A. & Gehlenborg, N. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics 33, 2938\u20132940. https:\/\/doi.org\/10.1093\/bioinformatics\/btx364 (2017).","journal-title":"Bioinformatics"},{"key":"54795_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13058-021-01462-3","volume":"23","author":"JO Brett","year":"2021","unstructured":"Brett, J. O., Spring, L. M., Bardia, A. & Wander, S. A. ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer. Breast Cancer Res. 23, 85. https:\/\/doi.org\/10.1186\/s13058-021-01462-3 (2021).","journal-title":"Breast Cancer Res."},{"key":"54795_CR52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4161\/epi.27111","volume":"9","author":"KE Williams","year":"2014","unstructured":"Williams, K. E., Anderton, D. L., Lee, M. P., Pentecost, B. T. & Arcaro, K. F. High-density array analysis of DNA methylation in Tamoxifen-resistant breast cancer cell lines. Epigenetics 9, 297\u2013307. https:\/\/doi.org\/10.4161\/epi.27111 (2014).","journal-title":"Epigenetics"},{"key":"54795_CR53","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.devcel.2010.10.005","volume":"19","author":"M Berdasco","year":"2010","unstructured":"Berdasco, M. & Esteller, M. Aberrant epigenetic lndscape in cancer: How cellular identity goes awry. Dev. Cell. 19, 698\u2013711. https:\/\/doi.org\/10.1016\/j.devcel.2010.10.005 (2010).","journal-title":"Dev. Cell."},{"key":"54795_CR54","doi-asserted-by":"publisher","first-page":"e1004996","DOI":"10.1371\/journal.pgen.1004996","volume":"11","author":"T Yuan","year":"2015","unstructured":"Yuan, T. et al. An integrative multi-scale analysis of the dynamic DNA methylation landscape in aging. PLoS Genet. 11, e1004996. https:\/\/doi.org\/10.1371\/journal.pgen.1004996 (2015).","journal-title":"PLoS Genet."},{"key":"54795_CR55","doi-asserted-by":"publisher","unstructured":"Patrick, R. et al. The activity of early-life gene regulatory elements is hijacked in aging through pervasive AP-1-linked chromatin opening. Cell Metab 36, 1858\u20131881 e1823 https:\/\/doi.org\/10.1016\/j.cmet.2024.06.006 (2024).","DOI":"10.1016\/j.cmet.2024.06.006"},{"key":"54795_CR56","doi-asserted-by":"publisher","unstructured":"Fu, X. et al. FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer. Proc. Natl. Acad. Sci. USA. 113 (E6600-e6609). https:\/\/doi.org\/10.1073\/pnas.1612835113 (2016).","DOI":"10.1073\/pnas.1612835113"},{"key":"54795_CR57","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.3390\/cancers13205205","volume":"13","author":"DD Seachrist","year":"2021","unstructured":"Seachrist, D. D., Anstine, L. J. & Keri, R. A. FOXA1: A pioneer of nuclear receptor action in breast cancer. Cancers 13, 5205 (2021).","journal-title":"Cancers"},{"key":"54795_CR58","doi-asserted-by":"publisher","unstructured":"Kleer, C. G. et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. USA 100, 11606\u201311611 https:\/\/doi.org\/10.1073\/pnas.1933744100 (2003).","DOI":"10.1073\/pnas.1933744100"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54795-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54795-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54795-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:30:28Z","timestamp":1785972628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54795-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54795"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54795-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All clinical-demographic data and patient-derived samples were collected under research protocols approved by the Institutional Review Board of Providence Health and Services (Protocol #: JWCI-18-0401). The experiments were performed following the World Medical Association Declaration of Helsinki and the National Institutes of Health Belmont Report. Tissues were de-identified following the Health Insurance Portability and Accountability Act (HIPAA) regulations. Validation data for this cross-sectional study were gathered from the publicly available dataset, The Cancer Genome Atlas (TCGA). This study followed the Strengthening of the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24254"}}